In a new letter, published in the Journal of the European Academy of Dermatology and Venereology, members of the lupus ...

Cutaneous vasculitis (CV) is a term used for inflammation of the blood vessels in the skin that occurs in up to 70% of patients with lupus erythematosus (LE). The inflammation affects the smaller ...

Systemic lupus erythematosus is associated with an increased risk for pulmonary manifestations, including ILD and pulmonary hypertension.

Incurable Autoimmune Disease Systemic Lupus Erythematosus (SLE): New Genetic Findings Open Up Perspectives for Future Therapeutic Approaches Jan. 14, 2024 — Systemic lupus erythematosus (SLE ...

inhibitor deucravacitinib has met the primary efficacy endpoints for the treatment of the skin manifestations of cutaneous lupus erythematosus (CLE). Unlike an earlier study, which was restricted ...

Systemic lupus erythematosus (SLE ... You might need medication to treat skin rashes, heart disease, or kidney problems associated with either condition. Sometimes, a combination of several ...

For treating systemic lupus erythematosus (SLE), the usual recommended ... It also comes as a liquid solution for injection under your skin. Some of the side effects of Saphnelo and Benlysta ...

As treatment approaches for cutaneous lupus erythematosus (CLE) continue to evolve, new data from Spherix Global Insights shed light on how specialists ...

The following is a summary of “Implementation outcomes of a patient decision-aid in a diverse population with systemic lupus ...

More than one-third of patients with systemic lupus erythematosus experience a flare after starting dialysis for end-stage renal disease, according to data published in Arthritis Care & Research.